SCHEMBL19488784

SCHEMBL19488784

CC(C)(C)OC(=O)N1CCC[C@H]1c1nc2ccc3cc(C#C[Si](C)(C)C)ccc3c2[nH]1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UCHL1 P09936 1/20 0.41
GABRG2 P18507 3/20 0.40
GABRB3 P28472 3/20 0.40
GABRA5 P31644 3/20 0.40
GABRA4 P48169 2/20 0.40
GABRA1 P14867 2/20 0.38
GABRA3 P34903 2/20 0.38
GABRA2 P47869 2/20 0.38
GABRA6 Q16445 2/20 0.38
ALDH1A1 P00352 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
HCRTR1 O43613 5/20 0.37
HCRTR2 O43614 5/20 0.37
CHEK2 O96017 1/20 0.36
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
GRM5 P41594 2/20 0.35
EPHX2 P34913 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201174 0.90 HCRTR1 (0.43) HCRTR1HCRTR2CHEK2
SCHEMBL10201488 0.89 L3MBTL1 (0.40) GABRG2GABRB3GABRA5GABRA4GABRA1
SCHEMBL203367 0.87 HCRTR1 (0.46) UCHL1GABRG2GABRB3GABRA5GABRA4
SCHEMBL2708720 0.87 HCRTR1 (0.46) UCHL1GABRG2GABRB3GABRA5GABRA4
SCHEMBL12373624 0.87 GABRA5 (0.37) UCHL1GABRG2GABRB3GABRA5GABRA4
SCHEMBL12373606 0.86 GABRA5 (0.38) UCHL1GABRG2GABRB3GABRA5GABRA4
SCHEMBL12373556 0.85 UCHL1 (0.43) UCHL1GABRG2GABRB3GABRA5GABRA4
SCHEMBL883264 0.85 CYP3A4 (0.42) HCRTR1HCRTR2CHEK2
SCHEMBL10202473 0.84 PTGES (0.40) L3MBTL1HCRTR1HCRTR2PTGES
SCHEMBL6125920 0.84 HCRTR1 (0.44) UCHL1ALDH1A1L3MBTL1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed